Literature DB >> 20351017

Definitive diagnosis of multiple myeloma from rib specimens resected at thoracotomy in a patient with lung cancer.

Taichiro Goto1, Arafumi Maeshima, Yoshitaka Oyamada, Ryoichi Kato.   

Abstract

A 52-year-old man noted large amounts of bloody sputum and visited our hospital. Chest X-ray showed a mass shadow in the right upper lung field. He was diagnosed with squamous cell carcinoma (SCC). Although he was not aware of symptoms other than the bloody sputum, his blood chemistry showed a high total serum protein level of 10.6 g/dl. Further analysis of serum immunoglobulin revealed a markedly high immunoglobulin G (IgG) level, but an abnormally low level of immunoglobulin A (IgA) and immunoglobulin M (IgM). Serum immunoelectrophoresis detected IgG-lambda monoclonal protein; therefore, we suspected the coexistence of multiple myeloma, amyloidosis, benign macroglobulinemia, or benign monoclonal gammopathy. Since the patient continued to expectorate large amounts of bloody sputum every day, and his anemia progressed, right upper lobectomy and lymph node dissection were performed on a semi-emergent basis without preoperative bone marrow examination. On thoracotomy at the level of the fifth intercostal space, the fifth and sixth ribs were partially resected posteriorly, and the resected ribs were submitted for pathological examination. The postoperative pathological diagnosis was SCC of the lung (p-T2N0M0, stage IB). Pathological examination of the ribs revealed IgG-lambda myeloma. Herein, we report a patient with lung cancer in whom multiple myeloma was definitively diagnosed from rib specimens resected at thoracotomy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351017     DOI: 10.1510/icvts.2009.230854

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Simultaneous multiple myeloma and non-small cell lung carcinoma: A case report and review of the literature.

Authors:  Huan-Huan Dong; Jing Li; Lin Kang; Qiang Wei; Yan Li
Journal:  Oncol Lett       Date:  2022-05-03       Impact factor: 3.111

2.  Multiple myeloma emerging after prolonged gefitinib treatment for non-small cell lung carcinoma.

Authors:  Sian Yik Lim; Sachiko Ando; Kaoru Nishiyama; Simi Padival
Journal:  Case Rep Oncol       Date:  2011-04-06

3.  Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report.

Authors:  Wenli Zuo; Xinghu Zhu; Jingke Yang; Zhenyang Mei; Mei Deng; Quande Lin; Yongping Song; Qingsong Yin
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

4.  Plasma cell myeloma initially presenting as lung cancer.

Authors:  Sun Young Cho; Jae-Heon Jeong; Woo-In Lee; Juhie Lee; Il Ki Hong; Jin-Tae Suh; Hee Joo Lee; Hwi-Joong Yoon; Tae Sung Park
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.